Isoleucine
If you find any inaccurate information, please let us know by providing your feedback here
Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C6H13NO2 131.17
l-Isoleucine CAS RN®: 73-32-5; UNII: 04Y7590D77.
1 DEFINITION
Isoleucine contains NLT 98.5% and NMT 101.5% of l-isoleucine (C6H13NO2), calculated on the dried basis
2 IDENTIFICATION
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K
3 ASSAY
Procedure
Sample: 130 mg of Isoleucine
Blank: Mix 3 mL of formic acid and 50 mL of glacial acetic acid.
Titrimetric system
(See Titrimetry 〈541〉.)
Mode: Direct titration
Titrant: 0.1 N perchloric acid VS
Endpoint detection: Potentiometric
Analysis: Dissolve the Sample in 3 mL of formic acid and 50 mL of glacial acetic acid. Titrate with the Titrant. Perform the blank determination.
Calculate the percentage of l-isoleucine (C6H13NO2) in the Sample taken:
Result = {[(VS − VB) × NA × F]/W} × 100
VS = Titrant volume consumed by the Sample (mL)
VB = Titrant volume consumed by the Blank (mL)
NA = actual normality of the Titrant (mEq/mL)
F = equivalency factor, 131.2 mg/mEq
W = Sample weight (mg)
Acceptance criteria: 98.5%–101.5% on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.3%
Chloride and Sulfate 〈221〉, Chloride
Standard solution: 0.50 mL of 0.020 N hydrochloric acid
Sample: 0.73 g of Isoleucine
Acceptance criteria: NMT 0.05%
Chloride and Sulfate 〈221〉, Sulfate
Standard solution: 0.10 mL of 0.020 N sulfuric acid
Sample: 0.33 g of Isoleucine
Acceptance criteria: NMT 0.03%
Change to read:
Iron 〈241〉, Procedures, Procedure 1 : NMT 30 ppm
Related Compounds
System suitability solution: 0.4 mg/mL each of USP l-Isoleucine RS and USP l-Valine RS in 0.1 N hydrochloric acid Standard solution: 0.05 mg/mL of USP l-Isoleucine RS in 0.1 N hydrochloric acid. [Note—This solution has a concentration equivalent to 0.5% of that of the Sample solution.]
Sample solution: 10 mg/mL of Isoleucine in 0.1 N hydrochloric acid
Chromatographic system
(See Chromatography 〈621〉, General Procedures, Thin-Layer Chromatography.)
Mode: TLC
Adsorbent: 0.25-mm layer of chromatographic silica gel mixture
Application volume: 5 µL
Developing solvent system: Butyl alcohol, glacial acetic acid, and water (3:1:1)
Spray reagent: 2 mg/mL of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5)
System suitability
Sample: System suitability solution
Suitability requirements: The chromatogram of the System suitability solution exhibits two clearly separated spots. Analysis
Samples: System suitability solution, Standard solution, and Sample solution
After air-drying the plate, spray with Spray reagent, and heat between 100° and 105° for 15 min. Examine the plate under white light. Acceptance criteria: Any secondary spot of the Sample solution is not larger or more intense than the principal spot of the Standard solution. Individual impurities: NMT 0.5%
Total impurities: NMT 2.0%
5 SPECIFIC TESTS
Optical Rotation 〈781S〉, Procedures, Specific Rotation
Sample solution: 40 mg/mL in 6 N hydrochloric acid
Acceptance criteria: +38.9° to +41.8° pH 〈791〉
Sample solution: 10 mg/mL in water Acceptance criteria: 5.5–7.0 Loss on Drying 〈731〉
Analysis: Dry at 105° for 3 h.
Acceptance criteria: NMT 0.3%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers.
USP Reference Standards 〈11〉
USP l-Isoleucine RS
USP l-Valine RS

